---
figid: PMC5817721__12943_2018_774_Fig2_HTML
figlink: /pmc/articles/PMC5817721/figure/Fig2/
number: Fig. 2
caption: Targeting RAF–MEK–ERK signaling pathway. GTP-bounding RAS recruits and activates
  RAF, which in turn initiates a cascade of protein phosphorylation starting with
  MEK. Activated MEK phosphorylates ERK that moves from the cytoplasm to the nucleus
  where it phosphorylates several transcription factors. Mutational activation of
  RAF–MEK–ERK cascade contributes to progression of the disease. Selective inhibitors
  of MEK, e.g. trametinib, cause potent and durable suppression of ERK signaling
pmcid: PMC5817721
papertitle: 'Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable
  targets in atypical chronic myeloid leukemia.'
reftext: Stefania Rocca, et al. Mol Cancer. 2018;17:40.
pmc_ranked_result_index: '17286'
pathway_score: 0.944771
filename: 12943_2018_774_Fig2_HTML.jpg
figtitle: Targeting RAF–MEK–ERK signaling pathway
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5817721__12943_2018_774_Fig2_HTML.html
  '@type': Dataset
  description: Targeting RAF–MEK–ERK signaling pathway. GTP-bounding RAS recruits
    and activates RAF, which in turn initiates a cascade of protein phosphorylation
    starting with MEK. Activated MEK phosphorylates ERK that moves from the cytoplasm
    to the nucleus where it phosphorylates several transcription factors. Mutational
    activation of RAF–MEK–ERK cascade contributes to progression of the disease. Selective
    inhibitors of MEK, e.g. trametinib, cause potent and durable suppression of ERK
    signaling
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K1
  - BRAF
  - NRAS
  - ARAF
  - MAPK3
  - MAPK1
  - HRAS
  - MAP2K2
  - RAF1
  - KRAS
  - Trametinib
genes:
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
chemicals:
- word: Trametinib
  source: MESH
  identifier: C560077
diseases: []
---
